94271 ⎘
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF
#2CYCLOALKYL CARBOXYLIC ACID DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF
#3COMPOUNDS FOR TREATMENT A CORONAVIRUS INFECTION
#4MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
#5COMPOUNDS
#6ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF
#7Pharmaceutical Compositions Having Improved Storage Stability
#8NOVEL AMINO ACID DERIVATIVES
#9FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM
#10HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS
#11ABIETANES AND METHODS OF MAKING AND USING THE SAME
#12POLYCYCLIC COMPOUND AND USE THEREOF
#13MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
#14SMALL MOLECULE PIM AND MTOR KINASE INHIBITOR AND METHODS OF USE THEREOF
#15NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS
#16MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
#17COMPOUNDS, COMPOSITIONS, AND METHODS FOR SELECTIVELY INHIBITING ß-GLUCURONIDASES AND ALLEVIATING SIDE EFFECTS ASSOCIATED WITH DRUG TREATMENT INDUCED DIARRHEA
#18CHIRAL BIMETALLIC COOPERATIVE CATALYSIS SYSTEM AND USE THEREOF IN ASYMMETRIC SYNTHESIS OF BEDAQUILINE
#19SULFONAMIDE OREXIN RECEPTOR AGONISTS AND USES THEREOF
#20Low-temperature continuous-flow preparation method of bedaquiline
#21Pharmaceutical compositions having improved storage stability
#22IL4I1 INHIBITORS AND METHODS OF USE
#23CDK2 INHIBITORS AND USES THEREOF
#24Aldehyde Dehydrogenase Inhibitors and Their Therapeutic Use
#25TYRAMINE CONTAINING HYDROXYCINNAMIC ACID AMIDE DERIVATIVES AND METHODS OF USE THEREOF
#26Abietanes and methods of making and using the same
#27MITOCHONDRIAL ATP INHIBITORS TARGETING THE GAMMA SUBUNIT PREVENT METASTASIS
#28REV-ERB AGONISTS
#29Combination Antibacterial Composition and Short-Course Antibacterial Regimen
#30SMALL MOLECULE INHIBITORS OF ENPP1
#31TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#32COMPOUND AS PPAR AGONIST AND APPLICATION THEREOF
#33NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF
#34Tetrahydrobenzoazepinones and Related Analogs for Inhibiting YAP/TAZ-TEAD
#35SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA
#36QUINOLINONE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS
#37Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#38TREATMENTS OF INFLAMMATORY BOWEL DISEASE
#39Heterocyclic compounds for the treatment of neurological and psychological disorders
#40Small molecule inhibitors of TEAD transcription factors
#412,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS
#42BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
#43SOLID FORM OF AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR
#44Stabilization of amyloidogenic immunoglobulin light chains
#45COMPOUNDS, COMPOSITIONS, AND METHODS FOR SELECTIVELY INHIBITING BETA-GLUCURONIDASES AND ALLEVIATING SIDE EFFECTS ASSOCIATED WITH DRUG TREATMENT INDUCED DIARRHEA
#46Pharmaceutical compositions having improved storage stability
#47LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCESSES FOR THE PREPARATION THEREOF
#48Modulators of mas-related g-protein receptor X4 and related products and methods
#49RADIOLABELLED COMPOUND OF A QUATERNARY AMMONIUM SALT OF A POLYCYCLIC AROMATIC AMINE AND METHODS OF MANUFACTURING AND DIAGNOSTIC USE THEREOF
#50HETEROARYL INHIBITORS OF PAD4
#51α,β-unsaturated amide compound
#52Catalyst bound alpha radical and synthesis of OXO compounds using the same
#53Histone methyltransferase inhibitors
#54Compounds, compositions, and methods for selectively inhibiting β-glucuronidases and alleviating side effects associated with drug treatment induced diarrhea
#552(1H)-QUINOLINONE DERIVATIVE
#56Compounds for inhibition of α4 β7 integrin
#572,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
#58Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose
#59Compounds for treatment of PD-L1 diseases
#60Heterocyclic compounds for the treatment of neurological and psychological disorders
#61Amine compound for inhibiting SSAO/VAP-1 and use thereof
#62Method for producing lactam compound, and lactam compound produced thereby
#63Compound as PPAR agonist and application thereof
#64Aromatic compound, pharmaceutical composition and use thereof
#65Pharmaceutical compositions having improved storage stability
#66Hydrophilic compounds for optically active devices
#67Aromatic compound, pharmaceutical composition and use thereof
#68COMBINATION ANTIBACTERIAL COMPOSITION AND SHORT-COURSE ANTIBACTERIAL REGIMEN
#69Catalyst-free and redox-neutral innate trifluoromethylation and alkylation of (hetero)aromatics enabled by light
#70Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#71Process and intermediates for the preparation of benzo[b]thiophene compounds
#72Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose
#73SMALL MOLECULE MODULATORS OF HUMAN STING
#74LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCESSES FOR THE PREPARATION THEREOF
#75FUSED-BICYCLIC ARYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
#76Process for the preparation of aripiprazole lauroxil
#77TYRAMINE CONTAINING HYDROXYCINNAMIC ACID AMIDE DERIVATIVES AND METHODS OF USE THEREOF
#78N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases
#79Heteroaryl inhibitors of PAD4
#80Methods and compositions for inhibition of bromodomain-containing proteins
#81Antibodies to aripiprazole haptens and use thereof
#82Heterocyclic compounds for the treatment of neurological and psychological disorders
#83Pharmaceutical compositions having improved storage stability
#84LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCESSES FOR THE PREPARATION THEREOF
#85PHENYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
#86BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS
#87Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
#88Methods of hydrofluorination
#89Modulators of ATP-binding cassette transporters
#90Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#91Heterocyclic compounds for the treatment of neurological and psychological disorders
#92Mutant IDH1 inhibitors useful for treating cancer
#93Endoparasite control agent
#94Process and intermediates for the preparation of benzo[b]thiophene compounds
#95High stress resistant plant growth regulator and preparation method and use thereof
#96QUINOLONE CHALCONE COMPOUNDS AND USES THEREOF
#97Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
#98PROCESSES FOR MAKING ALKYLATED ARYLPIPERAZINE AND ALKYLATED ARYLPIPERIDINE COMPOUNDS INCLUDING NOVEL INTERMEDIATES
#99Heterobicyclic compounds and their use for the treatment of tuberculosis
#1002,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
#101Crystal forms of bedaquiline fumarate and preparation methods therefor
#102Hydrophilic compounds for optically active devices
#103PROCESS FOR THE PREPARATION OF 5-AMINO-QUINOLIN-2(1H)-ONES AND THEIR TAUTOMER FORMS 5-AMINO-QUINOLIN-2-OLS
#104Multi-API loading prodrugs
#105Histone methyltransferase inhibitors
#106Compounds for optically active devices
#107Heterocyclic compounds for the treatment of neurological and psychological disorders
#108SHIP1 MODULATORS AND METHODS RELATED THERETO
#109Improved Process for the Preparation of Aripiprazole with Reduced Particle Size
#110Antibodies to aripiprazole haptens and use thereof
#111Therapeutic compounds
#112Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
#113Methods and compositions for inhibition of bromodomain-containing proteins
#114Bicyclic aryl sphingosine 1-phosphate analogs
#115Haptens of aripiprazole
#116Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates
#117Inhibitors of Late SV40 Factor (LSF) as cancer chemotherapeutics
#1182-oxo-3,4-dihydroquinoline compounds as plant growth regulators
#119Substituted 1-cycloalkyl-2-oxotetrahydroquinolin-6-ylsulfonamides or salts thereof and use thereof to increase stress tolerance in plants
#1202,4-dioxo-quinazoline-6-sulfonamide derivatives as inhibitors of PARG
#121Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#122Pesticidally active semi-carbazones and thiosemicarbazones derivatives
#123Pharmaceutical compositions having improved storage stability
#124Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#125SHIP1 modulators and methods related thereto
#126Compounds active towards bromodomains
#127Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#128Process for synthesizing oxidized lactam compounds
#129Heterobicyclic compounds and their use for the treatment of tuberculosis
#130SHIP1 MODULATORS AND METHODS RELATED THERETO
#131Bicyclic aryl sphingosine 1-phosphate analogs
#1322-oxo-3,4-dihydroquinolin-6-yl sulphonamide CPDS and their use as plant growth regulators
#133ORGANIC REACTIONS CARRIED OUT IN AQUEOUS SOLUTION IN THE PRESENCE OF A HYDROXYALKYL(ALKYL)CELLULOSE OR AN ALKYLCELLULOSE
#134Antibodies to aripiprazole haptens and use thereof
#135O-GLCNAC TRANSFERASE (OGT) INHIBITORS AND USES THEREOF
#136Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
#137IDENTIFICATION OF COMPOUNDS THAT DISPERSE TDP-43 INCLUSIONS
#138Haptens of aripiprazole
#139Inhibitors of late SV40 factor (LSF) as cancer chemotherapeutics
#140Substituted oxopyridine derivatives and use thereof as factor XIa/plasma
#141Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof
#142Therapeutic compounds
#143Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
#144Heterocyclic compounds for the treatment of neurological and psychological disorders
#145Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
#146Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#147Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#148Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#149Estrogen receptor modulators and uses thereof
#150Compositions for the treatment of hypertension and/or fibrosis
#151Arylquinoline and analog compounds and use thereof to treat cancer
#152COMPOUNDS THAT INDUCE ABA RESPONSES
#153NOVEL COMPOUND WITH ANTIBACTERIAL ACTIVITY
#154LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCE3SSES FOR THE PREPARATION THEREOF
#155Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
#156Store overload-induced calcium release inhibitors and methods for producing and using the same
#157Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency
#158Substituted oxopyridine derivatives and use thereof as factor xia/plasma
#159Bicyclic sulfonamide compounds as sodium channel inhibitors
#160Pharmaceutical compositions having improved storage stability
#161ROR MODULATORS AND THEIR USES
#162Bicyclic aryl sphingosine 1-phosphate analogs
#163Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
#164Anti-angiogenesis compound, intermediate and use thereof
#165Aryl-quinoline derivatives
#166COMPOUNDS FOR USE IN SCREENING METHODS FOR SPINAL MUSCULAR ATROPHY
#167Bicyclic sulfonamide compounds as sodium channel inhibitors
#168SHIP1 modulators and methods related thereto
#169Methods and compositions for inhibition of bromodomain-containing proteins
#170Chiral compounds, compositions, products and methods employing same
#171Process for synthesizing oxidized lactam compounds
#172Multi-API Loading Prodrugs
#1732,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
#174Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates
#175Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
#176Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use
#177Amine derivative or salt thereof
#178Therapeutic hydroxyquinolones
#179Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
#180Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#181Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof
#182DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR
#183CONJUGATES OF HUPERZINE AND ANALOGS THEREOF
#184Compound and asymmetric synthesis reaction
#185Activators of human pyruvate kinase
#186Rebamipide prodrugs, preparation method and use thereof
#187Secondary alcohol quinolinyl modulators of RORγt
#188MIF inhibitors and their uses
#189Polymorphic crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, heminapadisytlate as agonist of the β2 adrenergic receptor
#190Selective β-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
#191Synthetic compounds for vegetative ABA responses
#1922-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
#193Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
#194Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use
#195Bicyclic sulfonamide compounds as sodium channel inhibitors
#196Modulators of ATP-binding cassette transporters
#197Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
#198NITROGEN-CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF ATRIAL FIBRILLATION
#199BETA2-adrenoceptor agonists
#2002-carboxamide-4-piperazinyl-benzofuran derivative
#2012-(substituted-phenyl)-cyclopentane-1,3-dione compounds, and derivatives thereof
#202Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole
#203Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#204Bicyclic aryl sphingosine 1-phosphate analogs
#205COMPOUNDS FOR THE TREATMENT OF NEUROLOGIC DISORDERS
#206HIV replication inhibitor
#207Method for producing optically active tetrahydroquinolines
#208Method of modulating stress-activated protein kinase system
#209Agents and methods for treating ischemic and other diseases
#210Screening methods for spinal muscular atrophy
#211Haptens of aripiprazole
#212Aripiprazole type I microcrystal, aripiprazole solid preparations, and preparation method
#213Process for the preparation of anhydrous aripiprazole crystal form II
#214Heterobicyclic sphingosine 1-phosphate analogs
#215Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
#216Fused heterocyclic compounds as ion channel modulators
#217Pharmaceutical compositions having improved storage stability
#218Identification of compounds that disperse TDP-43 inclusions
#219Rebamipide complexes and cocrystals
#220NMDA receptor antagonists for neuroprotection
#221Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#222Viral polymerase inhibitors
#223Kappa opioid receptor agonists
#2246-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
#225Estrogen receptor modulators and uses thereof
#226Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use
#227SKIN LIGHTENING COMPOSITIONS
#228Chiral compounds, compositions, products and methods employing same
#2292-quinolinyl-acetic acid derivatives as HIV antiviral compounds
#230Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency
#231TRPV1 antagonists
#232Process for making sterile aripiprazole of desired mean particle size
#233Aryl-quinoline derivatives
#234ACTIVATORS OF HUMAN PYRUVATE KINASE
#235Fused heterocyclic compounds as ion channel modulators
#236Modulators of ATP-binding cassette transporters
#237QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
#238QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
#239Quinolinone derivatives as PARP and tank inhibitors
#240Estrogen receptor modulators and uses thereof
#241Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
#242Compounds which have activity at Mreceptor and their uses in medicine
#243Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#244Low hygroscopic aripiprazole drug substance and processes for the preparation
#245Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#246Beta-2-adrenoreceptor agonists
#247Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use
#248Method of modulating stress-activated protein kinase system
#249Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
#250Quinolinones and quinoxalinones as antibacterial composition
#251Viral polymerase inhibitors
#252METHODS FOR IDENTIFYING AND USING MarR FAMILY POLYPEPTIDE BINDING COMPOUNDS
#253Multi-API Loading Prodrugs
#254SELECTIVE INHIBITORS OF AKT AND METHODS OF USING SAME
#255Bicyclic aryl sphingosine 1-phosphate analogs
#256Quinolines and their therapeutic use
#257Quinoline derivatives as anti-cancer agents
#258Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
#259Quinolinone PDE2 inhibitors
#260Herbicidal quinoline and 1,8-naphthyridine compounds
#261Beta-2-adrenoreceptor agonists
#262Caspase inhibitors and uses thereof
#263Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#264Estrogen receptor modulators and uses thereof
#2656-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
#266Herbicides
#267Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#268Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
#269Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#270Process for preparing (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2- methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
#271Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
#272Ring-fused 2-pyridone derivatives and herbicides
#273Process for synthesizing oxidized lactam compounds
#274DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS
#275DI-SUBSTITUTED PHENYL COMPOUNDS
#276Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use
#277Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
#278Discodermolide analogues and methods of their use
#279PROCESS FOR MAKING STERILE ARIPIPRAZOLE OF DESIRED MEAN PARTICLE SIZE
#280Caspase inhibitors and uses thereof
#281NOVEL MYCOBACTERIAL INHIBITORS
#2826-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
#2836-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase CYP11B2
#284Bicyclic androgen and progesterone receptor modulator compounds and methods
#285QUINOLINE, NAPHTHALENE AND CONFORMATIONALLY CONSTRAINED QUINOLINE OR NAPHTHALENE DERIVATIVES AS ANTI-MYCOBACTERIAL AGENTS
#286Beta-2-adrenoreceptor agonists
#287Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof
#288Viral polymerase inhibitors
#289Methods for identifying and using MarR family polypeptide binding compounds
#290Heterocyclic compounds for the treatment of neurological and psychological disorders
#291Process for preparing anhydrous Aripirazole type I
#292TETRAHYDRONAPHTHALENE DERIVATES, PROCESS FOR PREPARING THEM AND THEIR USE AS ANTIINFLAMMATORY AGENTS
#293METHOD OF MODULATING STRESS-ACTIVATED PROTEIN KINASE SYSTEM
#294Quinolinone derivatives as PARP inhibitors
#295New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
#296Amine salt of carbostyril derivative
#297METHOD FOR SALT PREPARATION
#298Compounds which have activity at Mreceptor and their uses in medicine
#299Quinoline Derivatives as Antibacterial Agents
#300Quinoline Derivatives as Antibacterial Agents